FDA Grants Priority Review to Update Label for Sotatercept-Csrk - Prabadin Corp

https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

FDA Grants Priority Review to Update Label for Sotatercept-Csrk

Health

July 22, 2025

By AdminPrabadin - 2 months ago

0

Results from the ZENITH trial show sotatercept’s promise for pulmonary arterial hypertension treatment.

administrator